Published “Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial” in The Lancet Diabetes & Endocrinology — cited 293 times.
- #crossref
- #research
- #work